FAQ's

What is our device?

• TAIAAS (Transanal Intraluminal Anosomatic Access System) is a comprehensive colon resectioning solution offering multi-tiered advantages for clinicians, hospitals, and their patients. TAIAAS will give surgeons the ability to access the sigmoid colon and descending colon, via the anus, to completely remove cancerous segments of the large intestine and resection the colon, all within the body. Eliminating the need to perform an open surgery (Laparotomy). Our method will reduce the amount of trauma patients receive during surgery, hastening their recovery, and postoperative quality of life.

How does it work? 

• The device is inserted into the anus and passed through the rectum onward to the sigmoid or descending colon. Negative and positive pneumatic pressure is then used to grasp a section of the intestinal wall, inverting it into itself. Where it is then radially cut within the device's access tube. It can then be manipulated by the surgeon to separate the two sections of the intestine to perform the needed surgical procedure. 

*(Refer to the video on our homepage for a more detailed explanation)

Does it have other uses? 

• In the future, we aim to eventually grant access to the abdominal cavity. We believe that a multitude of common abdominal surgical procedures (appendectomies, cholecystectomy, laparoscopic procedures, biopsies, splenectomy, etc) could be completed in this way. Additionally, when scaled for use in the cardiovascular system, it will be able to repair aneurysms of the descending aorta via the femoral artery. 

Who would benefit from this device?

• Anyone in need of a colectomy within the sigmoid or descending colon, that requires an incision to be made in the abdominal wall or laparoscopy. 

How big is the market? 

• The colorectal procedure market in North America is worth 6.1 billion dollars (2023). Our device would be operating within the sigmoid and descending colon, which makes up 27% of all colorectal cancer procedures. Once commercialized, our goal is to capture 5% of the market within our first 3 years after funding.

When will it be available? 

• There is no set release date for our device. However, we are currently on the path to commercialization.

Why was this device created?

• This device was created to reduce the recovery time, pain, and scarring that patients experience following surgical procedures within their abdominal cavities. 

Is this device patented? 

• Yes, we have three US patents and one additional patent pending. 

How long will the procedure take? 

• We believe that we can complete a full resection surgery in 45-90 mins. 

How will this system prevent infection?

• By the structure and operation of the components of the device, along with proper irrigation, infection risk will be reduced.

How easy is it to use? 

• Our device works similarly in operation to current laparoscopic procedures. However, ease of use would depend on the skill of the surgeon.

What other devices will be used in conjunction with this device? 

• We suspect that existing laparoscopic tools and imaging devices will be used in conjunction with our device. Others may need to be pioneered in-house.

What stage of development is the device in?

• We have a semi-working prototype and several mockups.

What is the structure of your company? 

• Our company is currently registered as an S-corp in the state of California. 

What is your overall goal? 

• We are aiming to be acquired by a single large organization.